It was postulated that overexpression of SOX2 induces cancer stemness, tumor invasion, and drug resistance and is associated with poor survival in different types of cancers (Hou et al, 2015; Tang et al, 2013; Zhang et al, 2020). This evidence concerns the gene SOX2 and neoplasm.